GlassScriptPhysician profile
Patrice Webb
NPI 1851618086
$3,069.52
in general payments reported to CMS, 2019-2025
17 companies · $938 in 2025
The $938 reported for 2025 was more than what 82% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $233 · 2022: $357 · 2023: $553 · 2024: $989 · 2025: $938.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,480.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,479.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,510.70 | 2021-2025 | |
| Aimmune Therapeutics, INC. | $363.02 | 2024-2025 | Zenpep |
| Janssen Biotech, INC. | $294.97 | 2022-2025 | Tremfya, Stelara |
| Phathom Pharmaceuticals, INC. | $203.26 | 2024-2025 | Voquezna |
| Madrigal Pharmaceuticals | $125.48 | 2024 | Rezdiffra |
| Takeda Pharmaceuticals U.S.A., INC. | $110.00 | 2023-2024 | Gattex, Eohilia, Entyvio |
| Ironwood Pharmaceuticals, INC | $96.42 | 2023-2024 | Linzess |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $77.56 | 2024-2025 | Xifaxan |
| Pfizer INC. | $54.74 | 2023-2025 | |
| Regeneron Healthcare Solutions, INC. | $51.56 | 2025 | Dupixent |
| Merck Sharp & Dohme LLC | $42.65 | 2023-2024 | Dificid |
| Vivus LLC | $37.92 | 2024-2025 | Pancreaze |
| Alnylam Pharmaceuticals INC. | $29.38 | 2025 | Givlaari |
| Exact Sciences Corporation | $23.11 | 2023 | Cologuard Collection Kit |
| Braintree Laboratories, INC. | $17.98 | 2024 | Sutab, Suflave |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Laborie Medical Technologies Corp. | $15.87 | 2024 | Urgent PC Neuromodulation System |
| Boston Scientific Corporation | $14.90 | 2025 | Axonics |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrice Webb listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.